2020 12/11/2020 12:48 Management Discussion and Analysis Quarter 3 Ending 30 Sep 2020 (Edit No.2) 12/11/2020 09:15 Management Discussion and Analysis Quarter 3 Ending 30 Sep 2020 (Edit) 12/11/2020 08:27
Committee, Appointment of Audit Committee, Appointment of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Edit) 10/11/2021 08:33 Notification of
Management Discussion and Analysis Quarter 1 Ending 31 Mar 2022 22/02/2022 18:05 Management Discussion and Analysis Yearly Ending 31 Dec 2021(Edit) 21/02/2022 17:36 Management Discussion and Analysis Yearly
subsidiary company (Sabaijai Money Co., Ltd.) (edit) 15/11/2021 17:24 Report on the progress of a subsidiary company establishment (additional share acquisition in a joint venture company: Sabaijai Money Co
Time Heading Link 09/02/2023 18:45 Management Discussion and Analysis Yearly Ending 31 Dec 2022 03/11/2022 18:45 Management Discussion and Analysis Quarter 3 Ending 30 Sep 2022 (Edit) 03/11/2022 18:03
Chokwatana (Edit) 02/03/2021 08:14 Approval of transaction contract of rent with connected persons 02/03/2021 08:13 The Information of the connected transaction on receiving financial assistance Approved the
prepaid market which the Company sees the opportunity in steady growth in 2018. The Company plans to launch new services, e.g. money transfer service, bus ticket payment, utility bill payment, insurance
prepaid numbers in the country. There is still two third of customers in prepaid market which the Company sees the opportunity in steady growth in 2018. The Company plans to launch new services, e.g. money
achieve diversified and steady cash flows. 8. Source of Funds The Transaction of USD 2 Billion will be funded from the Company’s own internal resources and the Company will enter into the bridge loan
well as medical service concerning health and esthetics. 2. Overview of operating results in the Quarter 1’2018. The global economy has continued its steady growth as a result of a tightening monetary